| Argatroban side effects November, 2005 |
Brand Name: N/A
Active Ingredient: Argatroban
Strength(s): 100mg/ml
Dosage Form(s): Intravenous Injection
Company Name: Texas Biotechnology Corporation
Availability: Prescription only
*Date Approved by the FDA: June 30, 2000
*Approval by FDA does not mean that the drug is available for
consumers at this time.
--------------------------------------------------------------------------------
What is Argatroban used for?
Argatroban is used to treat and reduce the risk of blood clots in
patients who have had a reaction to heparin that resulted in
reduced platelets and associated blood clots.
Who should not be treated with Argatroban?
Argatroban should not be given to individuals who have major
bleeding.
Warnings with Argatroban:
Increased risk of bleeding is the most common complication of
Argatroban. If you have the following conditions, your risk of
bleeding may be increased:
severe high blood pressure
recent lumbar puncture, or spinal anesthesia
recent major surgery (especially involving the brain, spinal cord,
or eye)
medical conditions that increase the tendency to bleed
stomach ulcers
What should I tell my doctor or health care provider?
Because certain other medications can interact with Argatroban,
and may increase the risk of bleeding, review all medications
that you are taking with your health care provider, including
those that you take without a prescription.
Tell your doctor if you are taking blood thinners.
What are some possible side effects of Argatroban? (This list
is NOT a complete list of side effects reported with Argatroban.
Your health care provider can discuss with you a more complete
list of side effects.)
Bleeding is the most common side effect.
Other side effects may include:
Shortness of breath
Low blood pressure
Fever
Diarrhea
For more detailed information about Argatroban, ask your health care
provider.
Active Ingredient: Argatroban
Strength(s): 100mg/ml
Dosage Form(s): Intravenous Injection
Company Name: Texas Biotechnology Corporation
Availability: Prescription only
*Date Approved by the FDA: June 30, 2000
*Approval by FDA does not mean that the drug is available for
consumers at this time.
--------------------------------------------------------------------------------
What is Argatroban used for?
Argatroban is used to treat and reduce the risk of blood clots in
patients who have had a reaction to heparin that resulted in
reduced platelets and associated blood clots.
Who should not be treated with Argatroban?
Argatroban should not be given to individuals who have major
bleeding.
Warnings with Argatroban:
Increased risk of bleeding is the most common complication of
Argatroban. If you have the following conditions, your risk of
bleeding may be increased:
severe high blood pressure
recent lumbar puncture, or spinal anesthesia
recent major surgery (especially involving the brain, spinal cord,
or eye)
medical conditions that increase the tendency to bleed
stomach ulcers
What should I tell my doctor or health care provider?
Because certain other medications can interact with Argatroban,
and may increase the risk of bleeding, review all medications
that you are taking with your health care provider, including
those that you take without a prescription.
Tell your doctor if you are taking blood thinners.
What are some possible side effects of Argatroban? (This list
is NOT a complete list of side effects reported with Argatroban.
Your health care provider can discuss with you a more complete
list of side effects.)
Bleeding is the most common side effect.
Other side effects may include:
Shortness of breath
Low blood pressure
Fever
Diarrhea
For more detailed information about Argatroban, ask your health care
provider.
PHARMCEUTICAL
INDUSTRY
Foundamental
Science
Colloidal
Stabilization
Drug Product
Development
Patent Application
Product
Development
Product
Ingredients
Colorant
Scale up a batch 1
Drug Delivery
Industry
Drug Delivery -
Smart Bomb
Lotion, Cream,
Preps
Enteric
Coating-Eudragit
Enteric
Coating-Nutrateric
SR
Coating-Aquacoat
Drug Industry
Drug
Competitions
Drug in
Development
Cholesterol-loweri
ng
Drug-Terminologi
es
Packaging
Materials
Market
Drug Dev- 2004
Drug Dev -
2005Q1
Drug Dev- 2005Q2
Drug
Dev-2005Summer
Drug Dev-2005Q3
Orphan Drug
Protein Drug
Niche Market
Novo Norkdisk
R&D
Equipment
Blenders
CONTRACT
MANUFACT.
Nutrition
Supplements
NEW DRUGS
Arranon
Actoplus Met
Alfuzosin
Ambien CR
Avastin
Asmanex(R)
Erbitux
(cetuximab)
Gardasil
GRN163
Herceptin
Increlex (rhIGF-1)
Lidoerm
(Lidocaine)
Liraglutide
Lyrica (pregabalin)
Rozerem
Sorafenib
Sutent
Tamsulosin
Torcetrapib
Zometa
OLD DRUGS
Lithium Carbonate
DRUG NOTES
[CONSTRUCT]
Clinical Research
Terminologies
FDA ALERTS
Protein Drug
Market
Niche Market
Orphan Drug
levothyroxine
Protein Drug 1
Protein Drug2
Double-blind
Study
INDUSTRY
Foundamental
Science
Colloidal
Stabilization
Drug Product
Development
Patent Application
Product
Development
Product
Ingredients
Colorant
Scale up a batch 1
Drug Delivery
Industry
Drug Delivery -
Smart Bomb
Lotion, Cream,
Preps
Enteric
Coating-Eudragit
Enteric
Coating-Nutrateric
SR
Coating-Aquacoat
Drug Industry
Drug
Competitions
Drug in
Development
Cholesterol-loweri
ng
Drug-Terminologi
es
Packaging
Materials
Market
Drug Dev- 2004
Drug Dev -
2005Q1
Drug Dev- 2005Q2
Drug
Dev-2005Summer
Drug Dev-2005Q3
Orphan Drug
Protein Drug
Niche Market
Novo Norkdisk
R&D
Equipment
Blenders
CONTRACT
MANUFACT.
Nutrition
Supplements
NEW DRUGS
Arranon
Actoplus Met
Alfuzosin
Ambien CR
Avastin
Asmanex(R)
Erbitux
(cetuximab)
Gardasil
GRN163
Herceptin
Increlex (rhIGF-1)
Lidoerm
(Lidocaine)
Liraglutide
Lyrica (pregabalin)
Rozerem
Sorafenib
Sutent
Tamsulosin
Torcetrapib
Zometa
OLD DRUGS
Lithium Carbonate
DRUG NOTES
[CONSTRUCT]
Clinical Research
Terminologies
FDA ALERTS
Protein Drug
Market
Niche Market
Orphan Drug
levothyroxine
Protein Drug 1
Protein Drug2
Double-blind
Study
 |  |  |  |